Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pradat

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Clinics and Research in Hepatology and Gastroenterology|February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC studyFrançois Bailly, Victor Virlogeux, Cécilie Dufour, et al.
Plos One|November 24, 2021
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patientsAnne-Lise Bienvenu, Pierre Pradat, Alexandra Plesa, et al.
Hepatology (Baltimore, Md.)|April 14, 2011
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis CEric Trépo, Pierre Pradat, Andrej Potthoff, et al.
Trials|June 6, 2023
End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExtPierre Pradat, Solene Pantel, Marianne Maynard, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2009
Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of ageDidier Pinquier, Arnaud Gagneur, Laurent Balu, et al.
Plos Neglected Tropical Diseases|December 16, 2020
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in NepalSudhamshu Kc, Holly Murphy, Sameer Dixit, et al.
AIDS (London, England)|February 14, 2018
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIVPierre Pradat, Thomas Huleux, François Raffi, et al.
The Journal of Infection|June 6, 2017
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?Pierre Pradat, Pascal Pugliese, Isabelle Poizot-Martin, et al.
Clinical Drug Investigation|March 28, 2025
An Overview of Isavuconazole Clinical Use: A Multicentre Analysis of Indications, Exposure and Hepatic SafetyAnne-Lise Bienvenu, Alexandra Duffour, Claire Chatron, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological responseRoeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Clinics and Research in Hepatology and Gastroenterology|February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC studyFrançois Bailly, Victor Virlogeux, Cécilie Dufour, et al.
Plos One|November 24, 2021
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patientsAnne-Lise Bienvenu, Pierre Pradat, Alexandra Plesa, et al.
Hepatology (Baltimore, Md.)|April 14, 2011
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis CEric Trépo, Pierre Pradat, Andrej Potthoff, et al.
Trials|June 6, 2023
End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExtPierre Pradat, Solene Pantel, Marianne Maynard, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2009
Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of ageDidier Pinquier, Arnaud Gagneur, Laurent Balu, et al.
Plos Neglected Tropical Diseases|December 16, 2020
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in NepalSudhamshu Kc, Holly Murphy, Sameer Dixit, et al.
AIDS (London, England)|February 14, 2018
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIVPierre Pradat, Thomas Huleux, François Raffi, et al.
The Journal of Infection|June 6, 2017
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?Pierre Pradat, Pascal Pugliese, Isabelle Poizot-Martin, et al.
Clinical Drug Investigation|March 28, 2025
An Overview of Isavuconazole Clinical Use: A Multicentre Analysis of Indications, Exposure and Hepatic SafetyAnne-Lise Bienvenu, Alexandra Duffour, Claire Chatron, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological responseRoeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
Pageof 11